Fertility Futility: Procedures Claimed to Boost IVF Success Lack Supporting Evidence
By Sandy Ong,
Newsweek
| 01. 12. 2017
Natalie Fitzpatrick, 29, had been through three rounds of in vitro fertilization when her doctors suggested she try immunotherapy. Each of her IVF treatments had resulted in a miscarriage, and her doctors wanted to test her to see if there was something wrong with her immune system. But nearly $4,000 later, the additional testing proved fruitless. Fitzpatrick’s next two IVF cycles were unsuccessful—she miscarried once more—and she’s still trying.
Testing the immune system is one of a growing number of additional services offered to couples who can’t conceive through IVF treatment alone. Some clinics say they do it because certain antibodies can interfere with embryo implantation, but these claims are not backed by evidence. According to a study that appeared in the BMJ at the end of November, the same is true for many other extra services—of nearly 30 fertility clinic add-ons reviewed, only one increased a woman’s chances of having a baby. That was an endometrial scratch, in which a small nick is made in the uterus’s lining to increase the likelihood of an embryo implanting on it. And...
Related Articles
By Katie Hunt, CNN | 07.30.2025
Scientists are exploring ways to mimic the origins of human life without two fundamental components: sperm and egg.
They are coaxing clusters of stem cells – programmable cells that can transform into many different specialized cell types – to form...
By Rob Stein, NPR [cites CGS' Katie Hasson] | 08.06.2025
A Chinese scientist horrified the world in 2018 when he revealed he had secretly engineered the birth of the world's first gene-edited babies.
His work was reviled as reckless and unethical because, among other reasons, gene-editing was so new...
By Arthur Caplan and James Tabery, Scientific American | 07.28.2025
An understandable ethics outcry greeted the June announcement of a software platform that offers aspiring parents “genetic optimization” of their embryos. Touted by Nucleus Genomics’ CEO Kian Sadeghi, the $5,999 service, dubbed “Nucleus Embryo,” promised optimization of...
By Hannah Devlin, The Guardian | 07.05.2025
Scientists are just a few years from creating viable human sex cells in the lab, according to an internationally renowned pioneer of the field, who says the advance could open up biology-defying possibilities for reproduction.
Speaking to the Guardian, Prof...